February 23, 2024
Loading...
You are here:  Home  >  Banking & Finance  >  Tri-County Public Companies  -  Page 3
Latest

Limoneria’s 2023 revenues dip, fourth quarter up

By   /  Tuesday, December 26th, 2023  /  Agribusiness, Earnings, Latest news, left, Tri-County Public Companies  /  Comments Off on Limoneria’s 2023 revenues dip, fourth quarter up

Santa Paula-based Limoneira’s fiscal year 2023 revenues dipped 2.6% from fiscal year 2022, $179.9 million compared to $184.6 million, the agribusiness reported Dec. 21.  For the fourth quarter of fiscal year 2023, the company’s total net revenues were up 4.3% compared to fourth quarter 2022, $41.4 million to $39.7 million, the company said. Fiscal year Read More →

Latest

Limoneira stock jumps with possible sale announcement

By   /  Friday, December 8th, 2023  /  Agribusiness, Latest news, middle, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Limoneira stock jumps with possible sale announcement

Santa Paula-based Limoneira’s stock price has jumped about 24% since Dec. 1 when it announced it’s looking into selling some or all parts of the company to maximize value for its stockholders. The 130-year-old company, one of Ventura County’s largest agribusinesses, said another possibility could be a merger. Limoneira is a producer of lemons, avocados and other Read More →

Latest

Dubroff: A look ahead after a spectacular November for stock market

By   /  Thursday, December 7th, 2023  /  Banking & Finance, Columns, Latest news, Subscriber content, Tri-County Public Companies  /  Comments Off on Dubroff: A look ahead after a spectacular November for stock market

Henry Dubroff

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Arbitrator awards $155M in PennyMac dispute

By   /  Thursday, December 7th, 2023  /  Latest news, Law & Goverment, left, Subscriber content, Tri-County Public Companies  /  Comments Off on Arbitrator awards $155M in PennyMac dispute

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

AeroVironment crushes expectations but stock still falls

By   /  Wednesday, December 6th, 2023  /  Earnings, Latest news, middle, Subscriber content, Tri-County Economy, Tri-County Public Companies  /  Comments Off on AeroVironment crushes expectations but stock still falls

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Sutter Health sees expenses rise in the third quarter

By   /  Friday, December 1st, 2023  /  Earnings, Health Care & Life Science, Latest news, Subscriber content  /  Comments Off on Sutter Health sees expenses rise in the third quarter

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Acelyrin shares decline after programming error disclosure

By   /  Wednesday, November 29th, 2023  /  Earnings, Health Care & Life Science, Latest news, Top Stories, Top Story, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Acelyrin shares decline after programming error disclosure

Conejo Valley-based Acelyrin saw shares plummet more than 30% on Nov. 28 after the biotechnology startup announced an error in one of its trials for its main treatment. Acelyrin, which is a part of Westlake Village BioPartners investing portfolio, disclosed there was a programming error in a drug trial of izokibep, a treatment for psoriatic Read More →